SNDX – syndax pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals (SNDX) had its price target raised by The Goldman Sachs Group, Inc. from $28.00 to $34.00. They now have a "buy" rating on the stock.
Syndax Pharmaceuticals (SNDX) had its price target lowered by Mizuho from $45.00 to $43.00. They now have an "outperform" rating on the stock.
Syndax Pharmaceuticals (SNDX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $40.00 price target on the stock, down from $48.00.
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset [Yahoo! Finance]
Form SCHEDULE 13G/A Syndax Pharmaceuticals Filed by: VANGUARD GROUP INC
Form S-8 Syndax Pharmaceuticals
Form 10-K Syndax Pharmaceuticals For: Dec 31
Form 8-K Syndax Pharmaceuticals For: Feb 26
Form 4 Syndax Pharmaceuticals For: Feb 09 Filed by: Metzger Michael A
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.